Zinplava (bezlotoxumab) is a medication used to prevent repeat infection from a bacteria called Clostridioides difficile (C. diff). It's given as an injection into the veins for one dose only.
Prevention of another C. diff infection (CDI) in high-risk adults who are taking antibiotics for CDI
Zinplava (bezlotoxumab) is an antibody (a type of protein). It attaches to a toxin that the C. diff bacteria releases into your body and neutralizes it.
Source: DailyMed
Side effects that you should report to your care team as soon as possible:
Side effects that usually do not require medical attention (report to your care team if they continue or are bothersome):
Only used for preventing CDI from happening again (not for treatment)
Given as an IV injection by a healthcare provider
Brand name only, so might be expensive
Zinplava (bezlotoxumab) doesn't take the place of your antibiotic treatment for CDI. Make sure to continue to take your antibiotic(s) as prescribed to you.
Mark on your calendar your appointment to see your provider and receive your Zinplava (bezlotoxumab) dose.
Before receiving Zinplava (bezlotoxumab), be sure to tell your provider about your medical conditions, especially if you have heart failure.
Tell your provider if you're pregnant or breastfeeding. It isn't known if Zinplava (bezlotoxumab) will harm your baby if taken during pregnancy or if it passes into breast milk. Discuss the risks and benefits of this medication with your provider.
Zinplava (bezlotoxumab) can cause some serious health issues. This risk may be even higher for certain groups. If this worries you, talk to your doctor or pharmacist about other options.
Risk factors: History of heart failure
Zinplava (bezlotoxumab) can raise the risk of heart failure symptoms, especially if you have a history of heart failure. People with this heart problem should use Zinplava (bezlotoxumab) only if it's clearly needed. Before starting Zinplava (bezlotoxumab), make sure to tell your provider if you have heart failure. Contact your provider if you experience difficulty breathing, coughing or wheezing, swelling in your legs or ankles, low appetite, or if you get tired more easily after receiving Zinplava (bezlotoxumab). Your provider can check for heart failure through certain tests.
The typical dose is 10 mg/kg of body weight given as a single injection into the veins (intravenous, or IV) over 1 hour.
By signing up, I agree to GoodRx's Terms and Privacy Policy, and to receive marketing messages from GoodRx.
Research prescriptions and over-the-counter medications from A to Z, compare drug prices, and start saving.